New Centrum® VitaMints® offer a refreshingly new way to take a multivitamin
- Details
- Category: Pfizer
Pfizer Consumer Healthcare has announced the launch of Centrum®VitaMints®, a great-tasting and easy-to-take multivitamin that offers consumers the essential nutrients they can enjoy like a mint, from Centrum®, a brand they know and trust.
Daiichi Sankyo signs agreement with Translational Sciences, Inc. to develop and commercialize the first-in-class thrombus dissolving agent, TS23
- Details
- Category: Daiichi Sankyo
Daiichi Sankyo Company, Ltd. (hereafter, Daiichi Sankyo) has signed an exclusive licensing agreement with Translational Sciences, Inc. to develop and commercialize its novel thrombus (blood clot) dissolving agent, TS23, which is currently undergoing Phase I clinical trials.
Abbott is asking one million people worldwide. Here's why and how.
- Details
- Category: Abbott
What does it look like to really live a full life - one that enriches and satisfies, that provides happiness and enables achievement? Abbott is talking to one million people worldwide to find out. And the answers aren't as simple as you would think.
Boehringer Ingelheim and BioMed X apply crowdsourcing to establish a team of scientists for identifying key epigenetic regulators of COPD
- Details
- Category: Boehringer Ingelheim
Boehringer Ingelheim and BioMed X have successfully applied a crowdsourcing approach to establish a research team of outstanding scientists from around the world with bright ideas, who will endeavor to identify new approaches for the treatment of patients with chronic obstructive pulmonary disease (COPD).
Bayer aligns organization with Life Science businesses
- Details
- Category: Bayer
Following the economic and legal separation of Covestro, Bayer is charting the course for its successful development as a Life Science company. On Friday, the Supervisory Board approved the reorganization proposed by the Board of Management. From January 1, 2016, the company’s business will be managed by three divisions: Pharmaceuticals, Consumer Health and Crop Science.
International survey shows quality of patient-physician conversation at diagnosis linked to better patient outcomes
- Details
- Category: Boehringer Ingelheim
New research shows that the quality of patient-physician communication at diagnosis of type 2 diabetes (T2D) may impact future patient self-care and well-being.(1) Data from the IntroDia™ Survey, the largest international survey of its kind, have quantitatively demonstrated this link using responses from more than 10,000 people with T2D across 26 countries.(1,2)
Amgen to acquire privately-held Dezima Pharma
- Details
- Category: Amgen
Amgen (NASDAQ:AMGN) and Dezima Pharma B.V. (Dezima) today announced that the companies have entered into a definitive acquisition agreement under which Amgen will acquire Dezima, a privately-held, Netherlands-based biotechnology company focused on developing innovative treatments for dyslipidemia. Dezima shareholders have approved the agreement.
More Pharma News ...
- Amgen and Xencor announce strategic collaboration in cancer immunotherapy and inflammation
- New scholarships worth EUR 332,000 awarded by Bayer Foundation to promote international talents
- Johnson & Johnson announces BARDA funding award to accelerate Ebola vaccine program
- For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices
- Abbott named industry leader for responsible and sustainable business for three consecutive years on the Dow Jones Sustainability Index (DJSI)
- AstraZeneca purchases US biologics manufacturing facility to support growing pipeline
- Bristol-Myers Squibb Employees cycle nearly 2,900 miles to raise money for cancer research